Statins and Risk of New-Onset Diabetes Mellitus

被引：71
作者：
Shah, Ravi V. [3 ]
Goldfine, Allison B. [1 ,2 ]
机构：
[1] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[3] Harvard Univ, Div Cardiol, Dept Med, Massachusetts Gen Hosp, Boston, MA 02115 USA
来源：
CIRCULATION | 2012年 / 126卷 / 18期
关键词：
RANDOMIZED-TRIALS; ROSUVASTATIN; METAANALYSIS; CHOLESTEROL; THERAPY; PEOPLE;
D O I：
10.1161/CIRCULATIONAHA.112.122135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E282 / E284
页数：3
相关论文
共 7 条
  • [1] General cardiovascular risk profile for use in primary care - The Framingham Heart Study
    D'Agostino, Ralph B.
    Vasan, Ramachandran S.
    Pencina, Michael J.
    Wolf, Philip A.
    Cobain, Mark
    Massaro, Joseph M.
    Kannel, William B.
    [J]. CIRCULATION, 2008, 117 (06) : 743 - 753
  • [2] Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X
  • [3] The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
    Mihaylova, B.
    Emberson, J.
    Blackwell, L.
    Keech, A.
    Simes, J.
    Barnes, E. H.
    Voysey, M.
    Gray, A.
    Collins, R.
    Baigent, C.
    de Lemos, J.
    Braunwald, E.
    Blazing, M.
    Murphy, S.
    Downs, J. R.
    Gotto, A.
    Clearfield, M.
    Holdaas, H.
    Gordon, D.
    Davis, B.
    Koren, M.
    Dahlof, B.
    Poulter, N.
    Sever, P.
    Knopp, R. H.
    Fellstrom, B.
    Holdaas, H.
    Jardine, A.
    Schmieder, R.
    Zannad, F.
    Goldbourt, U.
    Kaplinsky, E.
    Colhoun, H. M.
    Betteridge, D. J.
    Durrington, P. N.
    Hitman, G. A.
    Fuller, J.
    Neil, A.
    Wanner, C.
    Krane, V.
    Sacks, F.
    Moye, L.
    Pfeffer, M.
    Hawkins, C. M.
    Braunwald, E.
    Kjekshus, J.
    Wedel, H.
    Wikstrand, J.
    Barter, P.
    Keech, A.
    [J]. LANCET, 2012, 380 (9841) : 581 - 590
  • [4] Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
    Ridker, Paul M.
    Danielson, Eleanor
    Fonseca, Francisco A. H.
    Genest, Jacques
    Gotto, Antonio M., Jr.
    Kastelein, John J. P.
    Koenig, Wolfgang
    Libby, Peter
    Lorenzatti, Alberto J.
    MacFadyen, Jean G.
    Nordestgaard, Borge G.
    Shepherd, James
    Willerson, James T.
    Glynn, Robert J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21) : 2195 - 2207
  • [5] Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
    Sattar, Naveed
    Preiss, David
    Murray, Heather M.
    Welsh, Paul
    Buckley, Brendan M.
    de Craen, Anton J. M.
    Seshasai, Sreenivasa Rao Kondapally
    McMurray, John J.
    Freeman, Dilys J.
    Jukema, J. Wouter
    Macfarlane, Peter W.
    Packard, Chris J.
    Stott, David J.
    Westendorp, Rudi G.
    Shepherd, James
    Davis, Barry R.
    Pressel, Sara L.
    Marchioli, Roberto
    Marfisi, Rosa Maria
    Maggioni, Aldo P.
    Tavazzi, Luigi
    Tognoni, Gianni
    Kjekshus, John
    Pedersen, Terje R.
    Cook, Thomas J.
    Gotto, Antonio M.
    Clearfield, Michael B.
    Downs, John R.
    Nakamura, Haruo
    Ohashi, Yasuo
    Mizuno, Kyoichi
    Ray, Kausik K.
    Ford, Ian
    [J]. LANCET, 2010, 375 (9716) : 735 - 742
  • [6] Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes-the CORALL study
    Simsek, S.
    Schalkwijk, C. G.
    Wolffenbuttel, B. H. R.
    [J]. DIABETIC MEDICINE, 2012, 29 (05) : 628 - 631
  • [7] Sukhija R, 2009, J INVEST MED, V57, P495, DOI 10.2310/JIM.0b013e318197ec8b
1